93 related articles for article (PubMed ID: 25455455)
1. Proteomic analysis of changes in the protein composition of MCF-7 human breast cancer cells induced by all-trans retinoic acid, 9-cis retinoic acid, and their combination.
Flodrova D; Benkovska D; Macejova D; Bialesova L; Hunakova L; Brtko J; Bobalova J
Toxicol Lett; 2015 Jan; 232(1):226-32. PubMed ID: 25455455
[TBL] [Abstract][Full Text] [Related]
2. Effects of retinoic acid isomers on proteomic pattern in human breast cancer MCF-7 cell line.
Flodrova D; Benkovska D; Macejova D; Bialesova L; Bobalova J; Brtko J
Endocr Regul; 2013 Oct; 47(4):205-9. PubMed ID: 24156709
[TBL] [Abstract][Full Text] [Related]
3. Consequences of the natural retinoid/retinoid X receptor ligands action in human breast cancer MDA-MB-231 cell line: Focus on functional proteomics.
Flodrova D; Toporova L; Lastovickova M; Macejova D; Hunakova L; Brtko J; Bobalova J
Toxicol Lett; 2017 Nov; 281():26-34. PubMed ID: 28886987
[TBL] [Abstract][Full Text] [Related]
4. Synergistic effects of retinoic acid and tamoxifen on human breast cancer cells: proteomic characterization.
Wang Y; He QY; Chen H; Chiu JF
Exp Cell Res; 2007 Jan; 313(2):357-68. PubMed ID: 17098229
[TBL] [Abstract][Full Text] [Related]
5. 13-cis retinoic acid and all-trans retinoic acid in the regulation of the proliferation and survival of human breast cancer cell line MCF-7.
Czeczuga-Semeniuk E; Wolczyński S; Dziecioł J; Dabrowska M; Anchim T; Tomaszewska I
Cell Mol Biol Lett; 2001; 6(4):925-39. PubMed ID: 11753438
[TBL] [Abstract][Full Text] [Related]
6. Effects of liarozole, a new antitumoral compound, on retinoic acid-induced inhibition of cell growth and on retinoic acid metabolism in MCF-7 human breast cancer cells.
Wouters W; van Dun J; Dillen A; Coene MC; Cools W; De Coster R
Cancer Res; 1992 May; 52(10):2841-6. PubMed ID: 1581897
[TBL] [Abstract][Full Text] [Related]
7. Novel retinoic acid metabolism blocking agents have potent inhibitory activities on human breast cancer cells and tumour growth.
Patel JB; Mehta J; Belosay A; Sabnis G; Khandelwal A; Brodie AM; Soprano DR; Njar VC
Br J Cancer; 2007 Apr; 96(8):1204-15. PubMed ID: 17387344
[TBL] [Abstract][Full Text] [Related]
8. Comparative proteomic analysis of colon cancer cell HCT-15 in response to all-trans retinoic acid treatment.
Zhao J; Wen G; Ding M; Pan JY; Yu ML; Zhao F; Weng XL; Du JL
Protein Pept Lett; 2012 Dec; 19(12):1272-80. PubMed ID: 22670670
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers of breast cancer apoptosis induced by chemotherapy and TRAIL.
Leong S; McKay MJ; Christopherson RI; Baxter RC
J Proteome Res; 2012 Feb; 11(2):1240-50. PubMed ID: 22133146
[TBL] [Abstract][Full Text] [Related]
10. [Screening proteins related to retinoic acid resistance by proteomic analysis].
Qin H; Liu T; Yang JL; Huang X; Liu B; Song X; Zhao X; Wei YQ
Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(8):520-5. PubMed ID: 17459200
[TBL] [Abstract][Full Text] [Related]
11. Retinoic acid attenuates promyelocytic leukemia protein-induced cell death in breast cancer cells by activation of the ubiquitin-proteasome pathway.
Son SH; Yu E; Ahn Y; Choi EK; Lee H; Choi J
Cancer Lett; 2007 Mar; 247(2):213-23. PubMed ID: 16740359
[TBL] [Abstract][Full Text] [Related]
12. 9-Cis retinoic acid inhibits growth of breast cancer cells and down-regulates estrogen receptor RNA and protein.
Rubin M; Fenig E; Rosenauer A; Menendez-Botet C; Achkar C; Bentel JM; Yahalom J; Mendelsohn J; Miller WH
Cancer Res; 1994 Dec; 54(24):6549-56. PubMed ID: 7987855
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of differential protein expression profile between retinoic acid resistant and sensitive acute promyelocytic leukemia cells].
Qin H; Liu T; Yang JL; Huang X; Liu B; Song X; Zhao X; Wei YQ
Ai Zheng; 2006 Jul; 25(7):828-32. PubMed ID: 16831272
[TBL] [Abstract][Full Text] [Related]
14. Proteomic identification of differentially expressed proteins in curcumin-treated MCF-7 cells.
Fang HY; Chen SB; Guo DJ; Pan SY; Yu ZL
Phytomedicine; 2011 Jun; 18(8-9):697-703. PubMed ID: 21239154
[TBL] [Abstract][Full Text] [Related]
15. CD44 and vimentin, markers involved with epithelial-mesenchymal transition: A proteomic analysis of sequential proteins extraction of triple-negative breast cancer cells after treatment with all-trans retinoic acid.
Strouhalova D; Macejova D; Lastovickova M; Brtko J; Bobalova J
Gen Physiol Biophys; 2020 Jul; 39(4):399-405. PubMed ID: 32902409
[TBL] [Abstract][Full Text] [Related]
16. The combined effects of all-trans-retinoic acid and docosahexaenoic acid on the induction of apoptosis in human breast cancer MCF-7 cells.
Abdolahi M; Shokri F; Hosseini M; Shadanian M; Saboor-Yaraghi AA
J Cancer Res Ther; 2016; 12(1):204-8. PubMed ID: 27072238
[TBL] [Abstract][Full Text] [Related]
17. Tunicamycin in combination with retinoic acid synergistically inhibits cell growth while decreasing palmitoylation and enhancing retinoylation of proteins in the human breast cancer cell line MCF-7.
Takahashi N; Iwahori A; Breitman TR; Fukui T
Oncol Res; 1997; 9(10):527-33. PubMed ID: 9507530
[TBL] [Abstract][Full Text] [Related]
18. Retinoic acid modulates prolactin receptor expression and prolactin-induced STAT-5 activation in breast cancer cells in vitro.
Widschwendter M; Widschwendter A; Welte T; Daxenbichler G; Zeimet AG; Bergant A; Berger J; Peyrat JP; Michel S; Doppler W; Marth C
Br J Cancer; 1999 Jan; 79(2):204-10. PubMed ID: 9888458
[TBL] [Abstract][Full Text] [Related]
19. Binding of retinoids to human breast cancer cell lines and their effects on cell growth.
Lacroix A; Lippman ME
J Clin Invest; 1980 Mar; 65(3):586-91. PubMed ID: 7188772
[TBL] [Abstract][Full Text] [Related]
20. [Proteomic analysis of proteins related to retinoid acid resistance].
Qin H; Liu T; Yang JL; Yang HS; Meng WT; Kan B; Wei YQ; Zhao X; Liu B; Song X
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jan; 37(1):133-6. PubMed ID: 16468662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
